Impact Partnership Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
35,952
+27,032
+303% +$1.55M 0.2% 71
2026
Q1
$541K Sell
8,920
-2,819
-24% -$164K 0.07% 190
2025
Q4
$633K Sell
11,739
-20,813
-64% -$1M 0.08% 162
2025
Q3
$1.47M Buy
32,552
+5,456
+20% +$255K 0.22% 53
2025
Q2
$1.25M Buy
27,096
+12,917
+91% +$634K 0.23% 44
2025
Q1
$865K Sell
14,179
-3,789
-21% -$221K 0.18% 56
2024
Q4
$1.02M Sell
17,968
-11
-0.1% -$615 0.21% 58
2024
Q3
$930K Buy
+17,979
New +$843K 0.21% 57
2024
Q2
Sell
-14,561
Closed -$790K 266
2024
Q1
$790K Sell
14,561
-2,112
-13% -$108K 0.31% 38
2023
Q4
$855K Buy
16,673
+15,082
+948% +$792K 0.31% 38
2023
Q3
$92.3K Sell
1,591
-3,459
-68% -$212K 0.03% 328
2023
Q2
$323K Buy
+5,050
New +$339K 0.11% 129

Other funds holding BMY

Impact Partnership Wealth's BMY Position: Q2 2026 in Review

Impact Partnership Wealth increased its Bristol-Myers Squibb (BMY) stake by 303% in Q2 2026, buying an estimated $1.55M and bringing the position to 35,952 shares worth $2.07M. The position accounts for 0.2% of the portfolio, ranked #71.

Impact Partnership Wealth first reported a position in BMY in Q2 2023 and has held it in 12 quarters since. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Impact Partnership Wealth held 35,952 shares of Bristol-Myers Squibb worth $2.07M as of Q2 2026.
  • Impact Partnership Wealth bought 27,032 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.55M.
  • Bristol-Myers Squibb made up 0.2% of Impact Partnership Wealth's portfolio in Q2 2026, its #71 holding.
  • Impact Partnership Wealth first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 12 quarters since.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Impact Partnership Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.